(Q48432075)

11 February 2018

title

Change in circulating C-reactive protein is not associated with atorvastatin treatment in Alzheimer's disease (English)

1 reference

11 February 2018

0 references

Goran Stankovic

1

1 reference

11 February 2018

D Larry Sparks

series ordinal

2

1 reference

11 February 2018

publication date

1 September 2006

1 reference

11 February 2018

published in

Neurological Research

1 reference

11 February 2018

volume

28

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

621-624

1 reference

11 February 2018

Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis

cites work

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Relation of plasma lipids to Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Statins and cognitive function in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

C-reactive protein comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Serum inflammatory proteins and cognitive decline in older persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Monitoring Progression in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X130452

21 January 2018

Identifiers

DOI

10.1179/016164106X130452

1 reference

11 February 2018

1 reference

11 February 2018